TY - JOUR
T1 - Immunological patterns identifying disease course and evolution in multiple sclerosis patients
AU - Furlan, Roberto
AU - Rovaris, Marco
AU - Boneschi, Filippo Martinelli
AU - Khademi, Mohsen
AU - Bergami, Alessandra
AU - Gironi, Maira
AU - Deleidi, Michela
AU - Agosta, Federica
AU - Franciotta, Diego
AU - Scarpini, Elio
AU - Uccelli, Antonio
AU - Zaffaroni, Mauro
AU - Kurne, Asli
AU - Comi, Giancarlo
AU - Olsson, Tomas
AU - Filippi, Massimo
AU - Martino, Gianvito
PY - 2005/8
Y1 - 2005/8
N2 - Reliable, and easy to measure, immunological markers able to denote disease characteristics in multiple sclerosis (MS) patients are still lacking. We applied a multivariate statistical analysis on results obtained by measuring-by real-time RT-PCR-mRNA levels of 25 immunological relevant molecules in PBMCs from 198 MS patients. The combined measurement of mRNA levels of IL-1β, TNF-α, TGF-β, CCL20 and CCR3 was able to distinguish MS patients from healthy individuals. CXCR5, CCL5, and CCR3 combined mRNA levels identify primary progressive MS patients while TNF-α, IL-10, CXCL10 and CCR3 differentiate relapsing MS patients. Our results indicate that multi-parametric analysis of mRNA levels of immunological relevant molecules in PBMCs may represent a successful strategy for the identification of putative peripheral markers of disease state and disease activity in MS patients.
AB - Reliable, and easy to measure, immunological markers able to denote disease characteristics in multiple sclerosis (MS) patients are still lacking. We applied a multivariate statistical analysis on results obtained by measuring-by real-time RT-PCR-mRNA levels of 25 immunological relevant molecules in PBMCs from 198 MS patients. The combined measurement of mRNA levels of IL-1β, TNF-α, TGF-β, CCL20 and CCR3 was able to distinguish MS patients from healthy individuals. CXCR5, CCL5, and CCR3 combined mRNA levels identify primary progressive MS patients while TNF-α, IL-10, CXCL10 and CCR3 differentiate relapsing MS patients. Our results indicate that multi-parametric analysis of mRNA levels of immunological relevant molecules in PBMCs may represent a successful strategy for the identification of putative peripheral markers of disease state and disease activity in MS patients.
KW - Chemokines
KW - Cytokines
KW - Multiple sclerosis
KW - Multivariate analysis
KW - Real-time RT-PCR
UR - http://www.scopus.com/inward/record.url?scp=22144434812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=22144434812&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2005.04.012
DO - 10.1016/j.jneuroim.2005.04.012
M3 - Article
C2 - 15949850
AN - SCOPUS:22144434812
VL - 165
SP - 192
EP - 200
JO - Journal of Neuroimmunology
JF - Journal of Neuroimmunology
SN - 0165-5728
IS - 1-2
ER -